Profile for Adaptimmune Therapeutics plc (ADAP)

$ 0.969   -0.0309 (-3.09%) Volume: 1.08m 4:00 PM EDT Oct 18, 2019
Business Description:
Adaptimmune Therapeutics PLC along with its subsidiaries is a clinical-stage biopharmaceutical company. It is engaged in novel cancer immunotherapy products based on its T-cell receptor platform.
Address: 60 Jubilee Avenue, Milton Park, Abingdon, Oxfordshire, GBR, OX14 4RY
Telephone: +44 1235430000 Website: http://www.adaptimmune.com
Facsimile: +44 1235430001 Email: [email protected]
Details
CEO: Adrian Rawcliffe
Employees: 430 Market Cap: 101.87m
Issue Type: CS
Auditor: KPMG LLP
Last Audit: Unqualified Opinion with Explanation
Indices: Biotechnology
Industry Classifications
Sector: Healthcare CIK: 1621227
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: N/A
SIC: Pharmaceutical Preparations (2834)